Cargando…
Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
Psoriasis is a chronic inflammatory skin disease that has a negative impact on psychosocial well-being and cardiometabolic health. Treatment options for moderate-to-severe psoriasis have expanded with the development of interleukin-17 (IL-17) inhibitors, the first of which is now available – secukin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066687/ https://www.ncbi.nlm.nih.gov/pubmed/27785085 http://dx.doi.org/10.2147/CCID.S81160 |